Titre : Sulfonamides

Sulfonamides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Problem-Based Learning
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sulfonamides : Questions médicales les plus fréquentes", "headline": "Sulfonamides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sulfonamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sulfonamides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sulfones", "url": "https://questionsmedicales.fr/mesh/D013450", "about": { "@type": "MedicalCondition", "name": "Sulfones", "code": { "@type": "MedicalCode", "code": "D013450", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Bumétanide", "alternateName": "Bumetanide", "url": "https://questionsmedicales.fr/mesh/D002034", "about": { "@type": "MedicalCondition", "name": "Bumétanide", "code": { "@type": "MedicalCode", "code": "D002034", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.150" } } }, { "@type": "MedicalWebPage", "name": "Diclofénamide", "alternateName": "Dichlorphenamide", "url": "https://questionsmedicales.fr/mesh/D004005", "about": { "@type": "MedicalCondition", "name": "Diclofénamide", "code": { "@type": "MedicalCode", "code": "D004005", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.410" } } }, { "@type": "MedicalWebPage", "name": "Mafénide", "alternateName": "Mafenide", "url": "https://questionsmedicales.fr/mesh/D008272", "about": { "@type": "MedicalCondition", "name": "Mafénide", "code": { "@type": "MedicalCode", "code": "D008272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.570" } } }, { "@type": "MedicalWebPage", "name": "Méfruside", "alternateName": "Mefruside", "url": "https://questionsmedicales.fr/mesh/D008529", "about": { "@type": "MedicalCondition", "name": "Méfruside", "code": { "@type": "MedicalCode", "code": "D008529", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.575" } } }, { "@type": "MedicalWebPage", "name": "Probénécide", "alternateName": "Probenecid", "url": "https://questionsmedicales.fr/mesh/D011339", "about": { "@type": "MedicalCondition", "name": "Probénécide", "code": { "@type": "MedicalCode", "code": "D011339", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.625" } } }, { "@type": "MedicalWebPage", "name": "Sulfamides", "alternateName": "Sulfanilamides", "url": "https://questionsmedicales.fr/mesh/D013424", "about": { "@type": "MedicalCondition", "name": "Sulfamides", "code": { "@type": "MedicalCode", "code": "D013424", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Furosémide", "alternateName": "Furosemide", "url": "https://questionsmedicales.fr/mesh/D005665", "about": { "@type": "MedicalCondition", "name": "Furosémide", "code": { "@type": "MedicalCode", "code": "D005665", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.300" } } }, { "@type": "MedicalWebPage", "name": "Sulfacétamide", "alternateName": "Sulfacetamide", "url": "https://questionsmedicales.fr/mesh/D013409", "about": { "@type": "MedicalCondition", "name": "Sulfacétamide", "code": { "@type": "MedicalCode", "code": "D013409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.650" } } }, { "@type": "MedicalWebPage", "name": "Sulfachlorpyridazine", "alternateName": "Sulfachlorpyridazine", "url": "https://questionsmedicales.fr/mesh/D013410", "about": { "@type": "MedicalCondition", "name": "Sulfachlorpyridazine", "code": { "@type": "MedicalCode", "code": "D013410", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.700" } } }, { "@type": "MedicalWebPage", "name": "Sulfadiazine", "alternateName": "Sulfadiazine", "url": "https://questionsmedicales.fr/mesh/D013411", "about": { "@type": "MedicalCondition", "name": "Sulfadiazine", "code": { "@type": "MedicalCode", "code": "D013411", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.755" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sulfadiazine d'argent", "alternateName": "Silver Sulfadiazine", "url": "https://questionsmedicales.fr/mesh/D012837", "about": { "@type": "MedicalCondition", "name": "Sulfadiazine d'argent", "code": { "@type": "MedicalCode", "code": "D012837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.755.800" } } } ] }, { "@type": "MedicalWebPage", "name": "Sulfadiazine d'argent", "alternateName": "Silver Sulfadiazine", "url": "https://questionsmedicales.fr/mesh/D012837", "about": { "@type": "MedicalCondition", "name": "Sulfadiazine d'argent", "code": { "@type": "MedicalCode", "code": "D012837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.755.800" } } }, { "@type": "MedicalWebPage", "name": "Sulfadiméthoxine", "alternateName": "Sulfadimethoxine", "url": "https://questionsmedicales.fr/mesh/D013412", "about": { "@type": "MedicalCondition", "name": "Sulfadiméthoxine", "code": { "@type": "MedicalCode", "code": "D013412", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.760" } } }, { "@type": "MedicalWebPage", "name": "Sulfadoxine", "alternateName": "Sulfadoxine", "url": "https://questionsmedicales.fr/mesh/D013413", "about": { "@type": "MedicalCondition", "name": "Sulfadoxine", "code": { "@type": "MedicalCode", "code": "D013413", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.765" } } }, { "@type": "MedicalWebPage", "name": "Sulfaguanidine", "alternateName": "Sulfaguanidine", "url": "https://questionsmedicales.fr/mesh/D013414", "about": { "@type": "MedicalCondition", "name": "Sulfaguanidine", "code": { "@type": "MedicalCode", "code": "D013414", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.810" } } }, { "@type": "MedicalWebPage", "name": "Sulfalène", "alternateName": "Sulfalene", "url": "https://questionsmedicales.fr/mesh/D013415", "about": { "@type": "MedicalCondition", "name": "Sulfalène", "code": { "@type": "MedicalCode", "code": "D013415", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.850" } } }, { "@type": "MedicalWebPage", "name": "Sulfamérazine", "alternateName": "Sulfamerazine", "url": "https://questionsmedicales.fr/mesh/D013416", "about": { "@type": "MedicalCondition", "name": "Sulfamérazine", "code": { "@type": "MedicalCode", "code": "D013416", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.853" } } }, { "@type": "MedicalWebPage", "name": "Sulfamétoxydiazine", "alternateName": "Sulfameter", "url": "https://questionsmedicales.fr/mesh/D013417", "about": { "@type": "MedicalCondition", "name": "Sulfamétoxydiazine", "code": { "@type": "MedicalCode", "code": "D013417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.857" } } }, { "@type": "MedicalWebPage", "name": "Sulfadimidine", "alternateName": "Sulfamethazine", "url": "https://questionsmedicales.fr/mesh/D013418", "about": { "@type": "MedicalCondition", "name": "Sulfadimidine", "code": { "@type": "MedicalCode", "code": "D013418", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.862" } } }, { "@type": "MedicalWebPage", "name": "Sulfaméthoxazole", "alternateName": "Sulfamethoxazole", "url": "https://questionsmedicales.fr/mesh/D013420", "about": { "@type": "MedicalCondition", "name": "Sulfaméthoxazole", "code": { "@type": "MedicalCode", "code": "D013420", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.867" } } }, { "@type": "MedicalWebPage", "name": "Sulfaméthoxypyridazine", "alternateName": "Sulfamethoxypyridazine", "url": "https://questionsmedicales.fr/mesh/D013421", "about": { "@type": "MedicalCondition", "name": "Sulfaméthoxypyridazine", "code": { "@type": "MedicalCode", "code": "D013421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.872" } } }, { "@type": "MedicalWebPage", "name": "Sulfamonométhoxine", "alternateName": "Sulfamonomethoxine", "url": "https://questionsmedicales.fr/mesh/D013422", "about": { "@type": "MedicalCondition", "name": "Sulfamonométhoxine", "code": { "@type": "MedicalCode", "code": "D013422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.877" } } }, { "@type": "MedicalWebPage", "name": "Sulfamoxole", "alternateName": "Sulfamoxole", "url": "https://questionsmedicales.fr/mesh/D013423", "about": { "@type": "MedicalCondition", "name": "Sulfamoxole", "code": { "@type": "MedicalCode", "code": "D013423", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.882" } } }, { "@type": "MedicalWebPage", "name": "Sulfanilamide", "alternateName": "Sulfanilamide", "url": "https://questionsmedicales.fr/mesh/D000077145", "about": { "@type": "MedicalCondition", "name": "Sulfanilamide", "code": { "@type": "MedicalCode", "code": "D000077145", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.885" } } }, { "@type": "MedicalWebPage", "name": "Sulfapyridine", "alternateName": "Sulfapyridine", "url": "https://questionsmedicales.fr/mesh/D013427", "about": { "@type": "MedicalCondition", "name": "Sulfapyridine", "code": { "@type": "MedicalCode", "code": "D013427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.900" } } }, { "@type": "MedicalWebPage", "name": "Sulfaquinoxaline", "alternateName": "Sulfaquinoxaline", "url": "https://questionsmedicales.fr/mesh/D013428", "about": { "@type": "MedicalCondition", "name": "Sulfaquinoxaline", "code": { "@type": "MedicalCode", "code": "D013428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.925" } } }, { "@type": "MedicalWebPage", "name": "Sulfaméthizol", "alternateName": "Sulfamethizole", "url": "https://questionsmedicales.fr/mesh/D013419", "about": { "@type": "MedicalCondition", "name": "Sulfaméthizol", "code": { "@type": "MedicalCode", "code": "D013419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.935.813" } } }, { "@type": "MedicalWebPage", "name": "Sulfisomidine", "alternateName": "Sulfisomidine", "url": "https://questionsmedicales.fr/mesh/D013443", "about": { "@type": "MedicalCondition", "name": "Sulfisomidine", "code": { "@type": "MedicalCode", "code": "D013443", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.940" } } }, { "@type": "MedicalWebPage", "name": "Sulfafurazol", "alternateName": "Sulfisoxazole", "url": "https://questionsmedicales.fr/mesh/D013444", "about": { "@type": "MedicalCondition", "name": "Sulfafurazol", "code": { "@type": "MedicalCode", "code": "D013444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.945" } } } ] }, { "@type": "MedicalWebPage", "name": "Sulfasalazine", "alternateName": "Sulfasalazine", "url": "https://questionsmedicales.fr/mesh/D012460", "about": { "@type": "MedicalCondition", "name": "Sulfasalazine", "code": { "@type": "MedicalCode", "code": "D012460", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.730" } } }, { "@type": "MedicalWebPage", "name": "Tamsulosine", "alternateName": "Tamsulosin", "url": "https://questionsmedicales.fr/mesh/D000077409", "about": { "@type": "MedicalCondition", "name": "Tamsulosine", "code": { "@type": "MedicalCode", "code": "D000077409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.863" } } }, { "@type": "MedicalWebPage", "name": "Xipamide", "alternateName": "Xipamide", "url": "https://questionsmedicales.fr/mesh/D014988", "about": { "@type": "MedicalCondition", "name": "Xipamide", "code": { "@type": "MedicalCode", "code": "D014988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.975" } } } ], "about": { "@type": "MedicalCondition", "name": "Sulfonamides", "alternateName": "Sulfonamides", "code": { "@type": "MedicalCode", "code": "D013449", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Reihane Ghomashi", "url": "https://questionsmedicales.fr/author/Reihane%20Ghomashi", "affiliation": { "@type": "Organization", "name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Shakila Ghomashi", "url": "https://questionsmedicales.fr/author/Shakila%20Ghomashi", "affiliation": { "@type": "Organization", "name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Hamidreza Aghaei", "url": "https://questionsmedicales.fr/author/Hamidreza%20Aghaei", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Ahmad Reza Massah", "url": "https://questionsmedicales.fr/author/Ahmad%20Reza%20Massah", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Satoru Suzuki", "url": "https://questionsmedicales.fr/author/Satoru%20Suzuki", "affiliation": { "@type": "Organization", "name": "Leading Academia in Marine and Environment Pollution Research (LaMer), Center for Marine Environmental Studies (CMES), Ehime University, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cross-sectional study of the quality of randomized control trials on problem-based learning in medical education.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36349397", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ca.23977" } }, { "@type": "ScholarlyArticle", "name": "From Slow Shifts to Fast Flips: Unraveling problem-based learning group function dynamics.", "datePublished": "2024-05-17", "url": "https://questionsmedicales.fr/article/38760834", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-05542-8" } }, { "@type": "ScholarlyArticle", "name": "Exploratory study on student perception on the use of chat AI in process-driven problem-based learning.", "datePublished": "2023-11-02", "url": "https://questionsmedicales.fr/article/37923639", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cptl.2023.10.001" } }, { "@type": "ScholarlyArticle", "name": "Development of self-regulation amongst dental students in problem-based learning curricula: A qualitative study.", "datePublished": "2022-05-30", "url": "https://questionsmedicales.fr/article/35579047", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/eje.12820" } }, { "@type": "ScholarlyArticle", "name": "Proposal of Design and Innovation in the Creation of the Internet of Medical Things Based on the CDIO Model through the Methodology of Problem-Based Learning.", "datePublished": "2022-11-20", "url": "https://questionsmedicales.fr/article/36433574", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s22228979" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Composés du soufre", "item": "https://questionsmedicales.fr/mesh/D013457" }, { "@type": "ListItem", "position": 4, "name": "Sulfones", "item": "https://questionsmedicales.fr/mesh/D013450" }, { "@type": "ListItem", "position": 5, "name": "Sulfonamides", "item": "https://questionsmedicales.fr/mesh/D013449" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sulfonamides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sulfonamides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sulfonamides", "description": "Comment diagnostiquer une infection nécessitant des sulfonamides ?\nQuels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?\nLes sulfonamides sont-ils efficaces contre toutes les bactéries ?\nQuels signes cliniques indiquent une infection bactérienne ?\nComment confirmer une infection urinaire ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Problem-Based+Learning&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sulfonamides", "description": "Quels sont les symptômes d'une infection traitée par sulfonamides ?\nLes sulfonamides provoquent-ils des effets secondaires ?\nComment reconnaître une réaction allergique aux sulfonamides ?\nQuels symptômes indiquent une surinfection ?\nLes sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Problem-Based+Learning&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sulfonamides", "description": "Comment prévenir les infections nécessitant des sulfonamides ?\nLes sulfonamides peuvent-ils être utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles à prévenir les infections ?\nComment éviter la résistance aux antibiotiques ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Problem-Based+Learning&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sulfonamides", "description": "Comment les sulfonamides sont-ils administrés ?\nQuelle est la posologie habituelle des sulfonamides ?\nLes sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?\nQuel suivi est nécessaire lors d'un traitement par sulfonamides ?\nLes sulfonamides sont-ils efficaces contre les infections virales ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Problem-Based+Learning&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sulfonamides", "description": "Quelles complications peuvent survenir avec les sulfonamides ?\nComment gérer une réaction allergique sévère aux sulfonamides ?\nLes sulfonamides peuvent-ils causer des troubles rénaux ?\nQuels signes indiquent une complication grave ?\nLes sulfonamides peuvent-ils interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Problem-Based+Learning&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sulfonamides", "description": "Qui est à risque de développer des effets secondaires aux sulfonamides ?\nLes personnes âgées sont-elles plus à risque avec les sulfonamides ?\nLes femmes enceintes peuvent-elles prendre des sulfonamides ?\nLes patients atteints de maladies hépatiques sont-ils à risque ?\nLes antécédents d'infections récurrentes augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Problem-Based+Learning&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection nécessitant des sulfonamides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des symptômes cliniques et des cultures bactériennes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de sensibilité aux antibiotiques sont réalisés sur des échantillons microbiologiques." } }, { "@type": "Question", "name": "Les sulfonamides sont-ils efficaces contre toutes les bactéries ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité varie selon le type de bactérie et leur résistance." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une infection bactérienne ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur, rougeur et gonflement peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment confirmer une infection urinaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un examen d'urine et une culture permettent de confirmer une infection urinaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection traitée par sulfonamides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur, fatigue et symptômes locaux selon l'infection." } }, { "@type": "Question", "name": "Les sulfonamides provoquent-ils des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets comme éruptions cutanées, nausées ou réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux sulfonamides ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Éruptions cutanées, démangeaisons, ou gonflement peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surinfection ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Augmentation de la douleur, fièvre persistante et écoulement purulent peuvent indiquer une surinfection." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir avec leur utilisation." } }, { "@type": "Question", "name": "Comment prévenir les infections nécessitant des sulfonamides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts avec des malades." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils être utilisés en prophylaxie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être prescrits en prophylaxie pour prévenir certaines infections." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter le partage d'objets personnels." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes." } }, { "@type": "Question", "name": "Comment éviter la résistance aux antibiotiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser les antibiotiques uniquement lorsque prescrit et suivre les recommandations médicales." } }, { "@type": "Question", "name": "Comment les sulfonamides sont-ils administrés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont généralement administrés par voie orale ou intraveineuse selon l'infection." } }, { "@type": "Question", "name": "Quelle est la posologie habituelle des sulfonamides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie selon l'infection, mais doit être prescrite par un médecin." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être utilisés en association pour élargir le spectre d'action." } }, { "@type": "Question", "name": "Quel suivi est nécessaire lors d'un traitement par sulfonamides ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier pour surveiller les effets secondaires et l'efficacité est recommandé." } }, { "@type": "Question", "name": "Les sulfonamides sont-ils efficaces contre les infections virales ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les sulfonamides ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les sulfonamides ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques graves, des troubles sanguins ou des lésions hépatiques peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer une réaction allergique sévère aux sulfonamides ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Cesser immédiatement le traitement et consulter un médecin pour un traitement approprié." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils causer des troubles rénaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles rénaux peuvent survenir, nécessitant une surveillance de la fonction rénale." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, éruption cutanée étendue ou difficulté respiratoire peuvent indiquer une complication." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils interagir avec d'autres médicaments ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent interagir avec d'autres médicaments, augmentant le risque d'effets secondaires." } }, { "@type": "Question", "name": "Qui est à risque de développer des effets secondaires aux sulfonamides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies médicamenteuses sont à risque accru." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque avec les sulfonamides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru d'effets secondaires et de complications." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles prendre des sulfonamides ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation doit être évitée, car elle peut affecter le fœtus. Consultez un médecin." } }, { "@type": "Question", "name": "Les patients atteints de maladies hépatiques sont-ils à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir un risque accru d'effets indésirables et nécessitent une surveillance." } }, { "@type": "Question", "name": "Les antécédents d'infections récurrentes augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents d'infections récurrentes peuvent nécessiter un traitement plus agressif." } } ] } ] }

Sous-catégories

31 au total
└─

Bumétanide

Bumetanide D002034 - D02.886.590.700.150
└─

Diclofénamide

Dichlorphenamide D004005 - D02.886.590.700.410
└─

Mafénide

Mafenide D008272 - D02.886.590.700.570
└─

Méfruside

Mefruside D008529 - D02.886.590.700.575
└─

Probénécide

Probenecid D011339 - D02.886.590.700.625
└─

Sulfamides

Sulfanilamides D013424 - D02.886.590.700.725
└─

Sulfasalazine

Sulfasalazine D012460 - D02.886.590.700.730
└─

Tamsulosine

Tamsulosin D000077409 - D02.886.590.700.863
└─

Xipamide

Xipamide D014988 - D02.886.590.700.975
└─└─

Furosémide

Furosemide D005665 - D02.886.590.700.725.300
└─└─

Sulfacétamide

Sulfacetamide D013409 - D02.886.590.700.725.650
└─└─

Sulfachlorpyridazine

Sulfachlorpyridazine D013410 - D02.886.590.700.725.700
└─└─

Sulfadiazine

Sulfadiazine D013411 - D02.886.590.700.725.755
└─└─

Sulfadiméthoxine

Sulfadimethoxine D013412 - D02.886.590.700.725.760
└─└─

Sulfadoxine

Sulfadoxine D013413 - D02.886.590.700.725.765
└─└─

Sulfaguanidine

Sulfaguanidine D013414 - D02.886.590.700.725.810
└─└─

Sulfalène

Sulfalene D013415 - D02.886.590.700.725.850
└─└─

Sulfamérazine

Sulfamerazine D013416 - D02.886.590.700.725.853
└─└─

Sulfamétoxydiazine

Sulfameter D013417 - D02.886.590.700.725.857
└─└─

Sulfadimidine

Sulfamethazine D013418 - D02.886.590.700.725.862
└─└─

Sulfaméthoxazole

Sulfamethoxazole D013420 - D02.886.590.700.725.867
└─└─

Sulfaméthoxypyridazine

Sulfamethoxypyridazine D013421 - D02.886.590.700.725.872
└─└─

Sulfamonométhoxine

Sulfamonomethoxine D013422 - D02.886.590.700.725.877
└─└─

Sulfamoxole

Sulfamoxole D013423 - D02.886.590.700.725.882
└─└─

Sulfanilamide

Sulfanilamide D000077145 - D02.886.590.700.725.885
└─└─

Sulfapyridine

Sulfapyridine D013427 - D02.886.590.700.725.900
└─└─

Sulfaquinoxaline

Sulfaquinoxaline D013428 - D02.886.590.700.725.925
└─└─

Sulfisomidine

Sulfisomidine D013443 - D02.886.590.700.725.940
└─└─

Sulfafurazol

Sulfisoxazole D013444 - D02.886.590.700.725.945
└─└─└─

Sulfadiazine d'argent

Silver Sulfadiazine D012837 - D02.886.590.700.725.755.800
└─└─└─

Sulfaméthizol

Sulfamethizole D013419 - D02.886.590.700.725.935.813

Sources (10000 au total)

From Slow Shifts to Fast Flips: Unraveling problem-based learning group function dynamics.

Problem-Based Learning (PBL) relies on self-directed learning in small groups in the presence of a tutor. While the effectiveness of PBL is often attributed to the dynamics of group function, change i... We examined time-function graphs of group function and conducted semi-structured focus group discussions in 2023 with medical students enrolled in a PBL curriculum. Students reflected on their experie... Three archetypes of PBL group function development were identified: Slow Shifters, Fast Flippers, and Coasters. (1) Slow Shifters were characterized by a complex and extended pattern of growth consist... PBL group function varies over time in 3 different patterns. Classic Tuckman's stages are apparent among inexperienced groups, or groups facing novel tasks, whereas experienced groups often face abrup...

Exploratory study on student perception on the use of chat AI in process-driven problem-based learning.

With the increasing prevalence of artificial intelligence (AI) technology, it is imperative to investigate its influence on education and the resulting impact on student learning outcomes. This includ... Eighteen students with prior experience in traditional PDPBL processes participated in the study, divided into three groups to perform PDPBL sessions with various triggers from pharmaceutical chemistr... The survey revealed that ChatGPT improved group collaboration and engagement during PDPBL, while increasing motivation and encouraging more questions. Nevertheless, some students encountered difficult... The study suggests that ChatGPT has the potential to enhance PDPBL in pharmacy education. However, further research is needed to examine the validity and reliability of the information provided by Cha...

Development of self-regulation amongst dental students in problem-based learning curricula: A qualitative study.

To explore the value of problem-based learning in the development of self-regulation amongst undergraduate dental students.... A qualitative approach using focus groups was used to explore the perceptions and experiences of the participants regarding the role of problem-based learning (PBL) in promoting self-regulation in und... A total of five focus groups were conducted with 37 participants which included 27 females and seven males from two different cohorts. Participants expressed their views on a range of issues related t... This study provides useful insights into the concept of self-regulation in problem-based learning environments as perceived by the stakeholders at a newly established dental institution. The findings ...

Application of the combination of three-dimensional visualization with a problem-based learning mode of teaching to spinal surgery teaching.

To explore the application of the combination of three-dimensional visualization technology with a problem-based learning mode of teaching in clinical teaching related to spinal surgery.... A total of 106 5-year undergraduate students who majored in clinical medicine were selected as research subjects, and practiced in the Orthopaedics Department of the Affiliated Hospital of Xuzhou Medi... The theoretical test total scores of students in the experimental group were higher than those of students in the control group. The students in the two groups self-rated their classroom achievements,... The application of a combination of 3D visualization technology with the PBL teaching mode to spinal surgery teaching can improve students' learning efficiency and interest and is conducive to cultiva...

Does problem-based learning facilitate enactment of learner agency in undergraduate dental curricula? A Q study.

Addressing a literature gap on leaner agency in health profession education, this study explores students' perceptions on which aspects of a problem-based learning (PBL) environment cradle their leane... Thirty-eight students from a newly established undergraduate dental medicine programme in Qatar participated in the study. Q methodology was adopted to collect and analyse data both qualitatively and ... Q methodological factor analysis identified four significantly different student viewpoints, which underscored participants' enactment of learner agency addressing the intrapersonal, behavioural and e... This study explored enactment of learner agency as perceived by undergraduate dental students in a PBL curriculum. The findings of this study provide new insights into participants' subjective underst...

Online-to-offline combined with problem-based learning is an effective teaching modality in the standardized residency training of nephrology.

The online-to-offline (O2O) teaching method is recognized as a new educational model that integrates network learning into offline classroom education, while problem-based learning (PBL) is a teaching... Sixty residency trainees who participated in the standardized training of internal medicine in the nephrology department of the Second Affiliated Hospital of Zhejiang University School of Medicine wer... Participants from the O2O/PBL group outperformed those from the LBT group in the examination of theory (81.233 ± 9.156 vs. 75.800 ± 7.009, mean ± SEM), practice skills (104.433 ± 3.569 vs.100.316 ± 4.... The current study shows the positive impact of O2O combined with PBL approach on standardized residency training in nephrology without reducing teaching satisfaction....

Effectiveness of a combined problem-based learning and flipped classroom teaching method in ophthalmic clinical skill training.

Previous studies have primarily implemented problem-based learning (PBL) or flipped classroom (FC) teaching models in different majors; however, research on the combined PBL-FC teaching method in clin... About 75 ophthalmology postgraduates were randomly divided into PBL-FC and traditional teaching groups. Students completed pre-and post-class theoretical examinations, skills evaluation, learning abil... Both groups showed significantly higher theoretical scores and improved learning ability. Feedback questionnaire scores of the PBL-FC group's postgraduates without clinical experience were significant... PBL-FC teaching is better for students without clinical experience or knowledge of ophthalmic diseases. Meanwhile, traditional teaching is a good choice for students with clinical experience who need ...

The effectiveness of problem-based learning and case-based learning teaching methods in clinical practical teaching in TACE treatment for hepatocellular carcinoma in China: a bayesian network meta-analysis.

To investigate the effectiveness of problem-based learning (PBL) and case-based learning (CBL) teaching methods in clinical practical teaching in transarterial chemoembolization (TACE) treatment in Ch... A comprehensive search of PubMed, the Chinese National Knowledge Infrastructure (CNKI) database, the Weipu database and the Wanfang database up to June 2023 was performed to collect studies that evalu... Finally, 7 studies (five RCTs and two observational studies) were included in the meta-analysis. The combination of PBL and CBL showed more effectiveness in clinical thinking capacity, clinical practi... Network meta-analysis revealed that the application of PBL combined with the CBL teaching mode in the teaching of liver cancer intervention therapy significantly improves the teaching effect and signi...